Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Lung Disease (ILD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07515066
What this trial is testing

Safety and Efficacy of Nebulized 3D-cultured Human Placental Mesenchymal Stem Cell-derived Extracellular Vesicles (hPMSC-EVs) for Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Huan Ye 9
Testing effectiveness (Phase 2)Looking for participantsNCT06325696
What this trial is testing

H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisLung Diseases, Interstitial
National Institute of Environmental Health Sciences (NIEHS) 37
Large-scale testing (Phase 3)Not Yet RecruitingNCT07210008
What this trial is testing

"Randomized Controlled Trial Testing the Efficacy of Corticosteroid Therapy Versus Placebo in Fibrotic Hypersensitivity Pneumonitis"

Who this might be right for
Hypersensitivity Pneumonitis
Assistance Publique - Hôpitaux de Paris 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT06665256
What this trial is testing

Phase 2 Study of Rapcabtagene Autoleucel in Myositis

Who this might be right for
Idiopathic Inflammatory Myopathies
Novartis Pharmaceuticals 21
Not applicableUnknownNCT06171425
What this trial is testing

Evaluation of Patients With Diffuse Parenchymal Lung Diseases Regarding Frailty

Who this might be right for
Diffuse Parenchymal Lung DiseaseFrailtyPhysical Inactivity
Hacettepe University 28
Testing effectiveness (Phase 2)Study completedNCT02888080
What this trial is testing

Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis

Who this might be right for
Pulmonary Sarcoidosis
Novartis Pharmaceuticals 40
Not applicableNot Yet RecruitingNCT07786090
What this trial is testing

Mechanistic 129 Xe MRI Study to Assess Therapeutic Response in Fibrotic Interstitial Lung Disease

Who this might be right for
Fibrotic Interstitial Lung Disease
Dr. Grace Parraga 35
Not applicableStudy completedNCT01487850
What this trial is testing

Wind Instruments' Fungal Contamination

Who this might be right for
Immunologically-induced Lung DiseaseHypersensitivity Pneumonitis
Centre Hospitalier Universitaire de Besancon
Testing effectiveness (Phase 2)Active Not RecruitingNCT05270668
What this trial is testing

Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)

Who this might be right for
Diffuse Cutaneous Systemic SclerosisInterstitial Lung Disease
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 154
Testing effectiveness (Phase 2)UnknownNCT01473797
What this trial is testing

Evaluation of Efficacy and Tolerance of Cladribine in Symptomatic Pulmonary Langerhans Cell Histiocytosis

Who this might be right for
Langerhans Cell Histiocytosis of Lung
Assistance Publique - Hôpitaux de Paris 10
Not applicableStudy completedNCT04148157
What this trial is testing

Quality of Life in IPF - Patient and Physician Perceptions

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Washington 100
Testing effectiveness (Phase 2)Study completedNCT03312400
What this trial is testing

Low-Dose Danazol for the Treatment of Telomere Related Diseases

Who this might be right for
Telomere Disease
National Heart, Lung, and Blood Institute (NHLBI) 18
Not applicableStudy completedNCT05394636
What this trial is testing

Cerebellar Superficial Siderosis in Cerebral Amyloid Angiopathy

Who this might be right for
Cerebral Amyloid AngiopathySiderosis
Centre Hospitalier Universitaire de Nīmes 111
Not applicableStudy completedNCT03770845
What this trial is testing

Nutritional Assessment in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
San Gerardo Hospital 100
Post-approval studies (Phase 4)UnknownNCT05505409
What this trial is testing

Efficacy and Safety of Pirfenidone in CTD-ILD

Who this might be right for
PirfenidoneConnective Tissue DiseasesInterstitial Lung Disease
Qilu Hospital of Shandong University 120
Large-scale testing (Phase 3)Ended earlyNCT05679401
What this trial is testing

A Study With Imlifidase in Anti-GBM Disease

Who this might be right for
Anti-Glomerular Basement Membrane DiseaseAnti-Glomerular Basement Membrane Antibody DiseaseGoodpasture Syndrome+1 more
Hansa Biopharma AB 50
Testing effectiveness (Phase 2)Study completedNCT03099187
What this trial is testing

Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease

Who this might be right for
Lung Diseases, Interstitial
Hoffmann-La Roche 253
Large-scale testing (Phase 3)Ended earlyNCT04552899
What this trial is testing

Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 665
Not applicableNot Yet RecruitingNCT06767904
What this trial is testing

Continuous Versus Demand-Based Oxygen in Patients With Fibrotic Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease

Who this might be right for
Interstitial Lung DiseaseChronic Obstructive Pulmonary Disease
Sissel Kronborg-White 60
Not applicableWithdrawnNCT05177471
What this trial is testing

Efficacy and Safety of JAK Inhibitors in Systemic Sclerosis-associated Interstitial Lung Disease

Who this might be right for
Systemic SclerosisInterstitial Lung Disease
Central Hospital, Nancy, France
Next Page